title: Antithrombotic therapy in atrial fibrillation.
authors.affiliation: Stanford Stroke Center, Palo Alto, CA 94304-1705, USA. albers@leland.stanford.edu
authors.forename: G W
authors.initials: GW
authors.lastname: Albers
authors.forename: J E
authors.initials: JE
authors.lastname: Dalen
authors.forename: A
authors.initials: A
authors.lastname: Laupacis
authors.forename: W J
authors.initials: WJ
authors.lastname: Manning
authors.forename: P
authors.initials: P
authors.lastname: Petersen
authors.forename: D E
authors.initials: DE
authors.lastname: Singer
mesh_terms: D000284:Administration, Oral; D000368:Aged; D001241:Aspirin / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000150:complications* / Q000188:drug therapy / Q000453:epidemiology; D004554:Electric Countershock; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D020300:Intracranial Hemorrhages / Q000453:epidemiology; D017063:Outcome Assessment, Health Care; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D018570:Risk Assessment; D020521:Stroke / Q000517:prevention & control*
chemical_list: D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors; D001241:Aspirin